On the other hand, There's a minority of scenarios where the remedy of EID utilizing the ICOC chelation protocol involving DF or L1 or their mixture will not be possible resulting from minimal tolerability or toxic side effects including allergic reactions in the course of parenteral infusion of DF or toxicity for example L1 agranulocytosis (Table